Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ranir buys Synpart businesses

This article was originally published in The Tan Sheet

Executive Summary

The Grand Rapids, Mich.-based oral care products firm acquires Synpart Ltd. and Synpart AG from HemCon Medical Technologies to build a "global oral-care footprint, increase its product offerings, expand its expertise in oral care and enhance its supply chain partnership network." Synpart is a leading manufacturer of store-brand oral-care products in Europe and contract manufacturer for oral-care companies globally. Ranir has a similar business model but also markets an "extensive" line of consumer oral-care products, including power and manual toothbrushes, tooth whitening wraps, tooth whitening trays, dissolving tooth whitening strips and dental floss. In a July 8 announcement, Ranir said it expects oral-care category growth "fueled by the growing awareness of the connection between oral health and overall wellness in developed countries worldwide.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104318

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel